Tumor Growth Control by Oral Trofosfamide in Patients with Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|21|1|52-56

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.1, 1998-03, pp. : 52-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Oral Trofosfamide in Elderly and/or Heavily Pretreated Patients with Metastatic Lung Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 4, 2000-09 ,pp. : 341-344

Karger

Access to resources Recommend Favorite

Dose Escalation Study for Defining the Maximum Tolerated Dose of Continuous Oral Trofosfamide in Pretreated Patients with Metastatic Lung Cancer

By  

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 534-538

Karger

Access to resources Recommend Favorite

Capecitabine for the oral treatment of metastatic breast cancer

By Cortés-Funes Hernán  

Women's Health, Vol. 2, Iss. 6, 2006-11 ,pp. : 805-817

Future Medicine

Access to resources Recommend Favorite

A Retrospective Analysis of the Activity and Safety of Oral Etoposide in Heavily Pretreated Metastatic Breast Cancer Patients

By  

THE BREAST JOURNAL, Vol. 21, Iss. 3, 2015-05 ,pp. : 241-245

John Wiley & Sons Inc

Access to resources Recommend Favorite

UFT plus Oral Folinic Acid with Alternating Oral and Intravenous Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes

By  

Oncology Research and Treatment, Vol. 32, Iss. 10, 2009-09 ,pp. : 562-566

Karger

Access to resources Recommend Favorite